In breast cancer, TIM and CDCA5 activate mTORC1/PI3K/AKT signaling, suppressing apoptosis while enhancing glycolysis through GLUT1/4 upregulation and HIF1α/c-Myc-mediated glycolytic enzyme synthesis [36,57,60]. Here, MYC is linked to breast carcinoma.